Herrera Cristian A, Lewin Simon, Paulsen Elizabeth, Ciapponi Agustín, Opiyo Newton, Pantoja Tomas, Rada Gabriel, Wiysonge Charles S, Bastías Gabriel, Garcia Marti Sebastian, Okwundu Charles I, Peñaloza Blanca, Oxman Andrew D
Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Marcoleta 434, Santiago, Chile.
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD011085. doi: 10.1002/14651858.CD011085.pub2.
Governance arrangements include changes in rules or processes that determine authority and accountability for health policies, organisations, commercial products and health professionals, as well as the involvement of stakeholders in decision-making. Changes in governance arrangements can affect health and related goals in numerous ways, generally through changes in authority, accountability, openness, participation and coherence. A broad overview of the findings of systematic reviews can help policymakers, their technical support staff and other stakeholders to identify strategies for addressing problems and improving the governance of their health systems.
To provide an overview of the available evidence from up-to-date systematic reviews about the effects of governance arrangements for health systems in low-income countries. Secondary objectives include identifying needs and priorities for future evaluations and systematic reviews on governance arrangements and informing refinements of the framework for governance arrangements outlined in the overview.
We searched Health Systems Evidence in November 2010 and PDQ Evidence up to 17 December 2016 for systematic reviews. We did not apply any date, language or publication status limitations in the searches. We included well-conducted systematic reviews of studies that assessed the effects of governance arrangements on patient outcomes (health and health behaviours), the quality or utilisation of healthcare services, resource use (health expenditures, healthcare provider costs, out-of-pocket payments, cost-effectiveness), healthcare provider outcomes (such as sick leave), or social outcomes (such as poverty, employment) and that were published after April 2005. We excluded reviews with limitations that were important enough to compromise the reliability of the findings of the review. Two overview authors independently screened reviews, extracted data and assessed the certainty of evidence using GRADE. We prepared SUPPORT Summaries for eligible reviews, including key messages, 'Summary of findings' tables (using GRADE to assess the certainty of the evidence) and assessments of the relevance of findings to low-income countries.
We identified 7272 systematic reviews and included 21 of them in this overview (19 primary reviews and 2 supplementary reviews). We focus here on the results of the 19 primary reviews, one of which had important methodological limitations. The other 18 were reliable (with only minor limitations).We grouped the governance arrangements addressed in the reviews into five categories: authority and accountability for health policies (three reviews); authority and accountability for organisations (two reviews); authority and accountability for commercial products (three reviews); authority and accountability for health professionals (seven reviews); and stakeholder involvement (four reviews).Overall, we found desirable effects for the following interventions on at least one outcome, with moderate- or high-certainty evidence and no moderate- or high-certainty evidence of undesirable effects. Decision-making about what is covered by health insurance- Placing restrictions on the medicines reimbursed by health insurance systems probably decreases the use of and spending on these medicines (moderate-certainty evidence). Stakeholder participation in policy and organisational decisions- Participatory learning and action groups for women probably improve newborn survival (moderate-certainty evidence).- Consumer involvement in preparing patient information probably improves the quality of the information and patient knowledge (moderate-certainty evidence). Disclosing performance information to patients and the public- Disclosing performance data on hospital quality to the public probably encourages hospitals to implement quality improvement activities (moderate-certainty evidence).- Disclosing performance data on individual healthcare providers to the public probably leads people to select providers that have better quality ratings (moderate-certainty evidence).
AUTHORS' CONCLUSIONS: Investigators have evaluated a wide range of governance arrangements that are relevant for low-income countries using sound systematic review methods. These strategies have been targeted at different levels in health systems, and studies have assessed a range of outcomes. Moderate-certainty evidence shows desirable effects (with no undesirable effects) for some interventions. However, there are important gaps in the availability of systematic reviews and primary studies for the all of the main categories of governance arrangements.
治理安排包括规则或流程的变化,这些变化决定了卫生政策、组织、商业产品和卫生专业人员的权力与问责,以及利益相关者在决策中的参与。治理安排的变化通常会通过权力、问责、开放性、参与度和连贯性的改变,以多种方式影响健康及相关目标。对系统评价结果进行全面概述,有助于政策制定者、其技术支持人员及其他利益相关者确定解决问题和改善卫生系统治理的策略。
概述来自最新系统评价的现有证据,这些证据涉及低收入国家卫生系统治理安排的影响。次要目的包括确定未来关于治理安排的评价和系统评价的需求与优先事项,并为概述中所述治理安排框架的完善提供信息。
我们于2010年11月检索了“卫生系统证据”,并截至2016年12月17日检索了“PDQ证据”以获取系统评价。检索时未应用任何日期、语言或出版状态限制。我们纳入了对评估治理安排对患者结局(健康和健康行为)、医疗服务质量或利用、资源使用(卫生支出、医疗服务提供者成本、自付费用、成本效益)、医疗服务提供者结局(如病假)或社会结局(如贫困、就业)影响的研究进行的高质量系统评价,且这些评价于2005年4月之后发表。我们排除了存在严重到足以损害评价结果可靠性的局限性的评价。两位概述作者独立筛选评价、提取数据并使用GRADE评估证据的确定性。我们为符合条件的评价编制了SUPPORT摘要,包括关键信息、“结果摘要”表(使用GRADE评估证据的确定性)以及对结果与低收入国家相关性的评估。
我们识别出7272项系统评价,并在本概述中纳入了其中21项(19项主要评价和2项补充评价)。我们在此重点关注19项主要评价的结果,其中一项存在重要的方法学局限性。其他18项可靠(仅有轻微局限性)。我们将评价中涉及的治理安排分为五类:卫生政策的权力与问责(三项评价);组织的权力与问责(两项评价);商业产品的权力与问责(三项评价);卫生专业人员的权力与问责(七项评价);以及利益相关者参与(四项评价)。总体而言,我们发现以下干预措施对至少一项结局有预期效果,证据确定性为中等或高,且无中等或高确定性证据表明存在不良效果。医疗保险覆盖范围的决策——对医疗保险系统报销的药品进行限制可能会减少这些药品的使用和支出(中等确定性证据)。利益相关者参与政策和组织决策——妇女参与式学习和行动小组可能会提高新生儿存活率(中等确定性证据)。——消费者参与编写患者信息可能会提高信息质量和患者知识水平(中等确定性证据)。向患者和公众披露绩效信息——向公众披露医院质量绩效数据可能会鼓励医院开展质量改进活动(中等确定性证据)。——向公众披露个体医疗服务提供者的绩效数据可能会使人们选择质量评级更高的提供者(中等确定性证据)。
研究人员已使用合理的系统评价方法评估了与低收入国家相关的广泛治理安排。这些策略针对卫生系统的不同层面,且研究评估了一系列结局。中等确定性证据表明某些干预措施有预期效果(无不良效果)。然而,在治理安排所有主要类别的系统评价和原始研究的可得性方面存在重要差距。